While biomarkers have greatly impacted the diagnosis and management of myocardial
infarction and heart failure, the use of biomarkers has been slow to permeate management …

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmias and associated with
the risk of stroke and death. Continuous development of the diagnostic tool and prognostic …

New biomarkers may help to understand the mechanisms of subclinical atrial fibrillation and
signal the likelihood of disease progression. Such biomarkers, though subject to further …

Assessment of atrial fibrillation (AF)-associated stroke risk is at present mainly based on
clinical risk scores such as CHADS2 and CHA2DS2-VASc, although these scores provide …

Improved diagnostic techniques have identified various biomarkers that might play an
important role in prediction of atrial fibrillation (AF) and related outcomes (cardio-and …

BACKGROUND Atrial fibrillation is the most common sustained arrhythmia and an important
contributor to cardiovascular morbidity and mortality. Several strategies have been proposed …

Background—Cardiac biomarkers are strong predictors of adverse outcomes in several
patient populations. We evaluated the prevalence of elevated troponin I and N-terminal pro …

Importance Treatment decisions in atrial fibrillation (AF) are based on clinical assessment of
risk. The CHA 2 DS 2-VASc (cardiac failure or dysfunction, hypertension, age 65-74 [1 point] …

Background: Atrial fibrillation is associated with an increased risk of death. High-sensitivity
troponin T, growth differentiation factor-15, NT-proBNP (N-terminal pro-B-type natriuretic …

Atrial fibrillation (AF) confers a raised risk of stroke and death, and this risk of adverse events
is increased by the coexistence of other cardiovascular risk factors. The pathophysiology of …